Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Arpida, Combio Collaborate For Antibiotics Discovery

Oct. 16, 2002

By Cormac Sheridan

Cytos Going Public By Way Of Merger With Swiss Company

Oct. 2, 2002

By Cormac Sheridan

Investors Hammer Genmab Stock Following Failure Of Lead Drug

Oct. 2, 2002

By Cormac Sheridan

Pharming Raises EUR8.2M In Equity, Debt, Prepares To Exit Moratorium

Oct. 2, 2002

By Cormac Sheridan

Investors Hammer Genmab Stock Following Failure Of Lead Drug

Oct. 2, 2002

By Cormac Sheridan

Cytos Going Public By Way Of Merger With Swiss Company

Oct. 2, 2002

By Cormac Sheridan

Pharming Raises EUR8.2M In Equity, Debt, Prepares To Exit Moratorium

Oct. 2, 2002

By Cormac Sheridan

Eirx Pharma Formed Through Three-Way Anglo-Irish Merger

Sep. 25, 2002

By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 25, 2002

By Cormac Sheridan

Eirx Pharma Formed Through Three-Way Anglo-Irish Merger

Sep. 25, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...